ADARx Pharmaceuticals, Inc. (ADRX)

Last Closing Price: 14.00 (2026-11-16)

Normalized Income after Taxes (Quarterly)

Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.

ADARx Pharmaceuticals, Inc. (ADRX) had Normalized Income after Taxes of $-28.12M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$2.22M
$-28.12M
--
$2.22M
$34.39M
$-32.18M
$4.06M
$-28.12M
$-28.12M
$-28.12M
$-28.12M
$-28.12M
Normalized Income after Taxes
$-28.12M
$-32.18M
$-32.18M
16.13M
16.13M
$-1.74
$-1.74
Balance Sheet Financials
$918.51M
$4.40M
$10.55M
$929.06M
$43.57M
--
$311.09M
$354.66M
$574.40M
$574.40M
$574.40M
107.26M
Cash Flow Statement Financials
$-76.75M
$78.61M
$502.10M
$66.52M
$570.61M
$504.09M
$4.27M
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--